Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer

被引:7
|
作者
Tezel, Cagatay [1 ]
Dogruyol, Talha [2 ]
Alpay, Levent [1 ]
Akyil, Mustafa [3 ]
Evman, Serdar [1 ]
Metin, Serda [1 ]
Baysungur, Volkan [1 ]
Yalcinkaya, Irfan [1 ]
机构
[1] Sureyyapasa Pulmonol & Thorac Surg Training & Res, Dept Thorac Surg, Istanbul, Turkey
[2] Manisa State Hosp, Dept Thorac Surg, TR-45020 Manisa, Turkey
[3] Canakkale State Hosp, Dept Thorac Surg, Canakkale, Turkey
来源
THORACIC AND CARDIOVASCULAR SURGEON | 2020年 / 68卷 / 02期
关键词
N1 lymph node; N2 lymph node; surgical treatment; survival rate; CLASSIFICATION; INVOLVEMENT; SURVIVAL; PATTERN; NUMBER; RATIO;
D O I
10.1055/s-0038-1675345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with N1 non-small cell lung cancer represent a heterogeneous population. The aim of this study is to determine the difference of survival rate between subtypes of N1 disease in surgically resected non-small cell lung cancer patients and to compare the survival in these patients with multi-N1 and single N2 (skip metastasis) disease. Methods Patients who underwent anatomical pulmonary resection in our institution between 2007 and 2014 with a pathological diagnosis of N1 and single N2 positive non-small cell lung cancer were included in the study. N1 positive patients were divided into three groups as single hilar; single interlobar, lobar, or segmental; and multiple N1 positive patients. These groups were compared among themselves as well as with incidentally found single N2 patients. Results A total of 1,742 patients who had non-small cell lung cancer underwent anatomical lung resection. The survival was better in single hilar lymph nodes than other subtypes of N1 disease ( p = 0.015). There was no statistically significant difference in terms of survival between the other subtypes of N1 disease ( p = 0.332). The difference in survival for single N2 disease compared with multi-N1 was not statistically significant ( p = 0.054). Also, when we divided the groups as single and multi-N1, there was a significant difference in survival ( p = 0.025). Conclusion Single hilar lymph nodes with direct invasion have better survival rate than other subtypes of N1. Also, patients with multiple N1 positive lymph nodes have similar survival results compared with single N2 patients. Our results should be confirmed with larger series to better explain N1 disease.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 50 条
  • [1] Prognostic significance of subcarinal lymph node metastasis in surgically resected non-small cell lung carcinoma
    Enatsu, S
    Iwasaki, A
    Maekawa, S
    Kawakami, T
    Hamasaki, M
    Myoshi, T
    Hiratsuka, M
    Yamamoto, S
    Shiraishi, T
    Shirakusa, T
    [J]. LUNG CANCER, 2005, 49 : S348 - S348
  • [2] Lymph node ratio is a prognostic factor for non-small cell lung cancer
    Sun, Guangyuan
    Xue, Lei
    Wang, Mingdong
    Zhao, Xuewei
    [J]. ONCOTARGET, 2015, 6 (32) : 33912 - 33918
  • [3] Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?
    David, Elizabeth A.
    Cooke, David T.
    Chen, Yingjia
    Nijar, Kieranjeet
    Canter, Robert J.
    Cress, Rosemary D.
    [J]. ANNALS OF THORACIC SURGERY, 2017, 103 (01): : 226 - 235
  • [4] The Survival Impact of Missed Lymph Node Metastasis in Surgically Resected Non-Small Cell Lung Cancer (NSCLC)
    Faris, Nicholas
    Smeltzer, Matthew P.
    Adair, Courtney
    Berry, Allen
    Yu, Xinhua
    Mchugh, Laura
    Osarogiagbon, Raymond U.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S334 - S335
  • [5] Prognostic factors for surgically resected non-small cell lung cancer with cavity formation
    Shigefuku, Shunsuke
    Kudo, Yujin
    Yunaiyama, Daisuke
    Matsubayashi, Jun
    Park, Jinho
    Nagao, Toshitaka
    Shimada, Yoshihisa
    Saji, Hisashi
    Hagiwara, Masaru
    Okano, Tetsuya
    Kakihana, Masatoshi
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 973 - +
  • [6] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Satoh, Hiroaki
    Iguchi, Kesato
    Nakamura, Ryota
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (04): : 314 - 314
  • [7] Prognostic role of nitrotyrosines in surgically resected non-small cell lung cancer (NSCLC)
    Toschi, L.
    Colombo, P.
    Soldani, C.
    Giordano, L.
    Finocchiaro, G.
    Siracusano, L.
    Gianoncelli, L.
    Incarbone, M.
    Destro, A.
    Alloisio, M.
    Terracciano, L.
    Varella-Garcia, M.
    Cappuzzo, F.
    Roncalli, M.
    Viola, A.
    Santoro, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Prognostic Factors for Surgically Resected Non-Small Cell Lung Cancer with Cavity Formation
    Shigefuku, S.
    Kudo, Y.
    Yunaiyama, D.
    Matsubayashi, J.
    Park, J.
    Nagao, T.
    Shimada, Y.
    Hagiwara, M.
    Saji, H.
    Okano, T.
    Kakihana, M.
    Kajiwara, N.
    Ohira, T.
    Ikeda, N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2408 - S2408
  • [9] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Moskalenko, Yuliia
    Smorodska, Olga
    Deineka, Volodymyr
    Kravets, Oleksandr
    Moskalenko, Roman
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (03): : 239 - 246
  • [10] Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases
    Casali, C
    Stefani, A
    Natali, P
    Rossi, G
    Morandi, U
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 28 (01) : 33 - 38